Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)
Clinical trial NCT06654336 · RECRUITING
Trial details
- NCT number
- NCT06654336
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2031-04-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.